X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ACTAVIS (US) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
ACTAVIS
Dec-14
ALEMBIC LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs7219,644-   
Low Rs3411,982-   
Sales per share (Unadj.) Rs4.73,537.4-  
Earnings per share (Unadj.) Rs6.1-441.4-  
Cash flow per share (Unadj.) Rs6.2324.5-  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.77,672.5-  
Shares outstanding (eoy) m267.03265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.5 252.0%   
Avg P/E ratio x8.7-35.8 -24.2%  
P/CF ratio (eoy) x8.548.7 17.4%  
Price / Book Value ratio x1.32.1 63.2%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1394,204,782 0.3%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM43,546.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-5,434.1-  
INCOME DATA
Net Sales Rs m1,255940,595 0.1%  
Other income Rs m370-2,348 -15.8%   
Total revenues Rs m1,625938,247 0.2%   
Gross profit Rs m111120,833 0.1%  
Depreciation Rs m38203,673 0.0%   
Interest Rs m229,668 0.0%   
Profit before tax Rs m442-114,856 -0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-8,425 0.0%   
Tax Rs m24-5,905 -0.4%   
Profit after tax Rs m1,630-117,376 -1.4%  
Gross profit margin %8.912.8 68.9%  
Effective tax rate %5.45.1 105.4%   
Net profit margin %129.8-12.5 -1,040.5%  
BALANCE SHEET DATA
Current assets Rs m1,867495,573 0.4%   
Current liabilities Rs m591361,418 0.2%   
Net working cap to sales %101.614.3 712.7%  
Current ratio x3.21.4 230.3%  
Inventory Days Days9458 162.5%  
Debtors Days Days7466 111.0%  
Net fixed assets Rs m1,791114,856 1.6%   
Share capital Rs m5340-   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,8582,040,115 0.5%   
Long term debt Rs m411,069,060 0.0%   
Total assets Rs m11,5913,738,860 0.3%  
Interest coverage x260.9-2.9 -9,085.7%   
Debt to equity ratio x00.5 0.7%  
Sales to assets ratio x0.10.3 43.0%   
Return on assets %14.1-2.3 -600.1%  
Return on equity %15.0-5.8 -260.9%  
Return on capital %15.2-3.0 -504.5%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m236161,518 0.1%  
From Investments Rs m-224-386,737 0.1%  
From Financial Activity Rs m-27217,290 -0.0%  
Net Cashflow Rs m-15-7,928 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.01 Rs / USD

Compare ALEMBIC LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC LTD With: PFIZER  J.B.CHEMICALS  MERCK LTD  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Sensex Ends 629 Points Higher; Realty and Auto Stocks Witness Buying(Closing)

Indian share markets continued their momentum throughout the day and ended the day on a strong note. Gains were largely seen in the realty sector, telecom sector and auto sector.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Dec 12, 2018 03:35 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - ALKEM LABORATORIES COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS